Literature DB >> 12507562

Efficacy of calfhood vaccination with Brucella abortus strain RB51 in protecting bison against brucellosis.

S C Olsen1, A E Jensen, W C Stoffregen, M V Palmer.   

Abstract

In the studies reported here, protection induced by calfhood vaccination of bison with 1.2-6.1 x 10(10)CFU of Brucella abortus strain RB51 (SRB51) against a virulent strain of B. abortus was evaluated. Non-vaccinated and SRB51-vaccinated bison were intraconjunctivally challenged during midgestation with 3 x 10(7)CFU of virulent B. abortus strain 2308 (S2308). Maternal and fetal tissues were obtained within 24hour after abortion or parturition. Incidence of abortion was greater (P<0.05) in non-vaccinated as compared to SRB51-vaccinated bison (62% and 15%, respectively), with abortions occurring between 5 and 8 weeks after experimental challenge. Calves from bison vaccinated with SRB51 had a reduced (P<0.05) prevalence of fetal infection with S2308 as compared to calves from non-vaccinated bison (19% and 62%, respectively). Although the ability to recover the 2308 challenge strain from maternal tissues did not differ (P>0.05) between nonvaccinates and vaccinates (100% and 78%, respectively), calfhood vaccination with SRB51 reduced (P<0.05) recovery of S2308 from uterine or mammary gland tissues. In bison which did not abort, S2308 was routinely recovered in low numbers from maternal lymphatic tissues; particularly the parotid, bronchial, supramammary, and mandibular lymph nodes. The RB51 vaccine strain was not recovered at any time from maternal or fetal samples obtained at necropsy. Histological lesions associated with Brucella-induced abortions were suppurative placentitis, fetal broncho-interstitial pneumonia, and fetal histiocytic splenitis. The results of our studies suggest that calfhood vaccination of bison with SRB51 is efficacious in protecting against intramammary, intrauterine, and fetal infection following exposure to a virulent strain of B. abortus during pregnancy. As brucellosis is transmitted horizontally through fluids associated with the birth or abortion of an infected fetus, or vertically to the calf through the ingestion of milk containing B. abortus, our data suggest that calfhood vaccination with SRB51 will be beneficial in preventing transmission of brucellosis in bison.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507562     DOI: 10.1016/s0034-5288(02)00146-7

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  11 in total

1.  Immune responses of elk to initial and booster vaccinations with Brucella abortus strain RB51 or 19.

Authors:  S C Olsen; S J Fach; M V Palmer; R E Sacco; W C Stoffregen; W R Waters
Journal:  Clin Vaccine Immunol       Date:  2006-10

2.  Serological and bacteriological responses of water buffalo (Bubalus bubalis) vaccinated with two doses of Brucella abortus strain RB51 vaccine.

Authors:  Anil Ramnanan; Michael Diptee; Zinora Asgarali; Mervyn Campbell; Abiodun Adewale Adesiyun
Journal:  Trop Anim Health Prod       Date:  2012-10       Impact factor: 1.559

3.  Comparative study on responses of cattle and water buffalo (Bubalus bubalis) to experimental inoculation of Brucella abortus biovar 1 by the intraconjunctival route--a preliminary report.

Authors:  Abiodun A Adesiyun; Geoff T Fosgate; Anil Persad; Mervyn Campbell; Ravi Seebaransingh; Alva Stewart-Johnson
Journal:  Trop Anim Health Prod       Date:  2010-07-08       Impact factor: 1.559

4.  Comparison of abortion and infection after experimental challenge of pregnant bison and cattle with Brucella abortus strain 2308.

Authors:  S C Olsen; C Johnson
Journal:  Clin Vaccine Immunol       Date:  2011-10-05

5.  Genetic bases of the rifampin resistance phenotype in Brucella spp.

Authors:  Cinzia Marianelli; Franco Ciuchini; Michela Tarantino; Paolo Pasquali; Rosanna Adone
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

6.  Efficacy of dart or booster vaccination with strain RB51 in protecting bison against experimental Brucella abortus challenge.

Authors:  S C Olsen; C S Johnson
Journal:  Clin Vaccine Immunol       Date:  2012-04-11

7.  Immune responses of bison and efficacy after booster vaccination with Brucella abortus strain RB51.

Authors:  S C Olsen; J L McGill; R E Sacco; S G Hennager
Journal:  Clin Vaccine Immunol       Date:  2015-02-11

8.  Immune responses and protection against experimental challenge after vaccination of bison with Brucella abortus strain RB51 or RB51 overexpressing superoxide dismutase and glycosyltransferase genes.

Authors:  S C Olsen; S M Boyle; G G Schurig; N N Sriranganathan
Journal:  Clin Vaccine Immunol       Date:  2009-01-28

9.  Progress in Brucella vaccine development.

Authors:  Xinghong Yang; Jerod A Skyberg; Ling Cao; Beata Clapp; Theresa Thornburg; David W Pascual
Journal:  Front Biol (Beijing)       Date:  2013-02-01

10.  Efficacy of strain RB51 vaccine in protecting infection and vertical transmission against Brucella abortus in Sprague-Dawley rats.

Authors:  Md Ariful Islam; Mst Minara Khatun; Byeong-Kirl Baek; Sung-Il Lee
Journal:  J Vet Sci       Date:  2009-09       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.